SU, sulfonylurea
Variants in GLP1R, GIPR, MC4R, and FTO can influence peptide response potential, though they do not determine outcomes
Ideal candidates for GLP-1 therapy, including Semaglutide and Tirzepatide treatments in NYC, are adults with a BMI of 27 or higher, particularly those with weight-related health issues
Your role is coaching, education, and accountability
Dose escalation is gradual to minimise gastrointestinal side effects such as nausea and vomiting
The gut microbiome's role in GLP-1 regulation is an active area of research, with emerging evidence suggesting that microbial diversity and specific bacterial strains may influence incretin hormone secretion, but more human studies are needed to establish clinical significance